We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLT icon
851
Hilton Worldwide
HLT
$72.6B
$3K ﹤0.01%
33
– –
KIE icon
852
State Street SPDR S&P Insurance ETF
KIE
$676M
$3K ﹤0.01%
+100
New +$3.29K
LEN icon
853
Lennar Class A
LEN
$20.5B
$3K ﹤0.01%
57
– –
LKFN icon
854
Lakeland Financial Corp
LKFN
$1.55B
$3K ﹤0.01%
69
– –
LULU icon
855
lululemon athletica
LULU
$13.7B
$3K ﹤0.01%
+17
New +$2.95K
NDAQ icon
856
Nasdaq
NDAQ
$53.5B
$3K ﹤0.01%
87
– –
NRG icon
857
NRG Energy
NRG
$25.4B
$3K ﹤0.01%
79
– –
NWN icon
858
Northwest Natural Holdings
NWN
$2.12B
$3K ﹤0.01%
36
– –
ACH
859
Accendra Health
ACH
$93.1M
$3K ﹤0.01%
1,000
– –
PDM
860
Piedmont Realty Trust
PDM
$1.19B
$3K ﹤0.01%
169
– –
PSEC icon
861
Prospect Capital
PSEC
$1.15B
$3K ﹤0.01%
500
– –
RNST icon
862
Renasant Corp
RNST
$3.96B
$3K ﹤0.01%
89
– –
RVTY icon
863
Revvity
RVTY
$13.2B
$3K ﹤0.01%
28
– –
SCHH icon
864
Schwab US REIT ETF
SCHH
$11.3B
$3K ﹤0.01%
152
-68
-31% -$1.52K
SCHM icon
865
Schwab US Mid-Cap ETF
SCHM
$15.2B
$3K ﹤0.01%
168
– –
STAG icon
866
STAG Industrial
STAG
$7.12B
$3K ﹤0.01%
103
– –
STE icon
867
Steris
STE
$23.1B
$3K ﹤0.01%
22
– –
SXT icon
868
Sensient Technologies
SXT
$5.55B
$3K ﹤0.01%
37
– –
TRMK icon
869
Trustmark
TRMK
$2.79B
$3K ﹤0.01%
86
– –
UA icon
870
Under Armour Class C
UA
$2.2B
$3K ﹤0.01%
125
– –
UDR icon
871
UDR
UDR
$12B
$3K ﹤0.01%
68
– –
UHS icon
872
Universal Health Services
UHS
$10.2B
$3K ﹤0.01%
23
– –
URI icon
873
United Rentals
URI
$70.3B
$3K ﹤0.01%
24
– –
VBR icon
874
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$3K ﹤0.01%
22
– –
WAFD icon
875
WaFd
WAFD
$2.79B
$3K ﹤0.01%
92
– –
33 34
35
36 37

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.